CareCloud (NASDAQ:CCLD) Issues Quarterly Earnings Results

Posted by Brian Himes on Aug 6th, 2026

CareCloud (NASDAQ:CCLD – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.02 by $0.04, Zacks reports. CareCloud had a net margin of 7.87% and a return on equity of 24.05%. The firm had revenue of $31.88 million during the quarter, compared to analyst estimates of $31.85 million. CareCloud updated its FY 2026 guidance to 0.200-0.230 EPS.

Here are the key takeaways from CareCloud’s conference call:

Revenue grew 16% year over year to $31.9 million, while recurring technology-enabled solutions increased to approximately 75% of revenue from 69% a year ago. Management also reported $5.7 million in quarterly free cash flow and the ninth consecutive quarter of GAAP profitability.
CareCloud completed the redemption of its Series B preferred stock using a $50 million credit facility, eliminating approximately $3.3 million in annual preferred dividends with no common-share dilution. The move is expected to improve the portion of earnings attributable to common shareholders, although debt interest will increase.
The acquisition of Empower Healthcare & Compliance Partners expands CareCloud into compliance, audit defense, and regulatory readiness, with plans to launch AI-enabled compliance software in fall 2026. Management said the near-term financial contribution will be limited, but it sees cross-selling and recurring SaaS potential across both CareCloud and Empower customers.
CareCloud reaffirmed 2026 guidance for revenue of $128 million to $132 million, adjusted EBITDA of $29 million to $31 million, and GAAP EPS of $0.20 to $0.23. Achieving the outlook requires a stronger second half, supported by recurring-revenue growth, enterprise expansion, cross-selling, and lower integration-related costs.
Second-quarter GAAP net income fell to $1.1 million from $2.9 million a year earlier, while adjusted EBITDA declined to $5.9 million from $6.8 million. Management attributed the pressure to higher AI and R&D investment, acquisition integration and amortization costs, and interest expense from the preferred-stock refinancing.

CareCloud Stock Down 8.9%

CareCloud stock traded down $0.23 during midday trading on Thursday, reaching $2.31. The stock had a trading volume of 1,920,975 shares, compared to its average volume of 249,228. CareCloud has a 12 month low of $2.03 and a 12 month high of $4.01. The firm’s 50-day moving average price is $2.29 and its 200 day moving average price is $2.62. The firm has a market capitalization of $98.37 million, a PE ratio of 21.05 and a beta of 1.51.

Hedge Funds Weigh In On CareCloud

Large investors have recently modified their holdings of the business. Essex Investment Management Co. LLC purchased a new stake in shares of CareCloud during the fourth quarter worth $2,000,000. Geode Capital Management LLC grew its position in shares of CareCloud by 235.4% in the second quarter. Geode Capital Management LLC now owns 359,486 shares of the company’s stock valued at $848,000 after purchasing an additional 252,299 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of CareCloud by 96.1% during the 4th quarter. Renaissance Technologies LLC now owns 446,030 shares of the company’s stock valued at $1,302,000 after purchasing an additional 218,530 shares during the period. Acadian Asset Management LLC lifted its holdings in CareCloud by 481.9% during the 1st quarter. Acadian Asset Management LLC now owns 203,053 shares of the company’s stock worth $280,000 after purchasing an additional 168,156 shares in the last quarter. Finally, 683 Capital Management LLC bought a new position in CareCloud in the 4th quarter worth about $467,000. Hedge funds and other institutional investors own 10.16% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CCLD shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CareCloud in a report on Wednesday, June 24th. Wall Street Zen cut CareCloud from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $3.25.

Get Our Latest Report on CCLD

About CareCloud

(Get Free Report)

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.